XBiotech Inc.
XBIT
$2.27
-$0.04-1.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.54M | -29.16M | -28.16M | -39.41M | -38.53M |
| Total Depreciation and Amortization | 1.69M | 1.75M | 1.76M | 1.76M | 1.75M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 294.00K | 6.03M | 4.46M | 8.36M | 7.28M |
| Change in Net Operating Assets | 3.64M | -2.12M | -3.15M | -1.19M | -1.46M |
| Cash from Operations | -39.92M | -23.51M | -25.09M | -30.48M | -30.96M |
| Capital Expenditure | -289.00K | -339.00K | -567.00K | -1.14M | -1.30M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -289.00K | -339.00K | -567.00K | -1.14M | -1.30M |
| Total Debt Issued | -- | 250.00K | 250.00K | 250.00K | 10.25M |
| Total Debt Repaid | -10.25M | -10.25M | -10.25M | -10.25M | -- |
| Issuance of Common Stock | -- | 33.00K | 97.00K | 145.00K | 200.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -10.25M | -9.97M | -9.90M | -9.86M | 10.45M |
| Foreign Exchange rate Adjustments | 3.33M | -1.94M | -28.00K | -3.66M | -5.53M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.13M | -35.75M | -35.59M | -45.14M | -27.35M |